Latest News about NVS
Recent news which mentions NVS
Novartis Precision Cancer Therapy Hits Primary Goal In Rare Type Of Pancreatic Cancer
September 25, 2023
Tickers
NVS
From Benzinga
Paramount Global and Netflix stock boosted by possible end to writer’s strike as Nike shares slip on downgrade
September 25, 2023
From MarketWatch
AI To Revolutionize Clinical Trials And Diagnostics
September 22, 2023
From Benzinga
From Years to Months: How AI is Shaping the Landscape of Clinical Trials
September 22, 2023
From Benzinga
From Benzinga
Chinese Drugmaker BeiGene And Novartis Move Out From Second Cancer Drug Pact
September 19, 2023
From Benzinga
AMC Stock Alert: Adam Aron Teases New Chocolate, Wine Brands for AMC
September 15, 2023
From InvestorPlace
Why Is Canopy Growth (CGC) Stock Up 14% Today?
September 15, 2023
From InvestorPlace
NVS Stock Alert: Novartis Shareholders Approve Sandoz Spinoff
September 15, 2023
From InvestorPlace
From Benzinga
From Benzinga
2 Dividend Stocks to Buy and Hold Forever
September 13, 2023
From Motley Fool
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
From Benzinga
From Benzinga
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
September 11, 2023
From Benzinga
Could This Biosimilar Drug Be Novartis' Next Blockbuster?
September 05, 2023
From Motley Fool
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
September 02, 2023
From Motley Fool
From Benzinga
From Motley Fool
From MarketWatch
Important Data Ahead, Tesla Turning On Massive Nvidia Cluster, 10 Drugs Name For Price Cuts
August 29, 2023
From Benzinga
From Benzinga
From InvestorPlace
3 Emerging Market Stocks to Buy in August
August 28, 2023
From InvestorPlace
Exelixis' Lead Cancer Treatment Delivers Another Surprise, Though Analyst Finds Commercial Opportunity In Pancreatic Neuroendocrine Modest
August 24, 2023
From Benzinga
Cheaper Version Of Blockbuster Arthritis Treatment Humira - CVS Health Teams With Sandoz
August 24, 2023
From Benzinga
Could This Medicine Be the Next Winner for Novartis?
August 23, 2023
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.